We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




AI Automatically Segments Kidneys and Measures Total Kidney Volumes Using Only 3D Ultrasound Images

By MedImaging International staff writers
Posted on 02 May 2022
Print article
Image: A first-ever study has applied deep learning to 3D US in ADPKD (Photo courtesy of Pexels)
Image: A first-ever study has applied deep learning to 3D US in ADPKD (Photo courtesy of Pexels)

Total kidney volume (TKV) is the most important imaging biomarker for quantifying the severity of autosomal-dominant polycystic kidney disease (ADPKD). 3D ultrasound (US) can accurately measure kidney volume compared to 2D US; however, manual segmentation is tedious and requires expert annotators. Now, the first study applying deep learning to 3D US in ADPKD has shown promising performance for auto-segmentation of kidneys using 3D US to measure TKV, close to human tracing and MRI measurement.

The imaging and analysis method developed by researchers at the Mayo Clinic (Rochester, MN, USA) could be useful in a number of settings, including pediatric imaging, clinical studies, and longitudinal tracking of patient disease progression. ADPKD is a genetic disorder in which cysts develop within the kidneys, causing kidneys to enlarge and lose function over time. Over time, kidney and liver volumes steadily increase, resulting in renal function decline. There is no cure for PKD, but dialysis, kidney transplant, blood pressure medication, and surgical removal of cysts are treatment options. If diagnosed and monitored at an early stage, better treatment options are possible.

Measuring kidney and liver volumes are some of the most important biomarkers in quantifying the severity of ADPKD and are used in clinical decision making. Apart from MRI and CT imaging, ultrasound (US) imaging is popular and widely used to diagnose acute and chronic kidney diseases. Imaging features computed from US data using deep CNNs improved the classification of children with congenital abnormalities of the kidney and urinary tract and controls. However, the computation of these anatomic measures typically involves manual or semi-automatic segmentation of kidneys in US images, requiring multiple human annotators, increasing inter-operator variability, reducing reliability, and limiting utility in clinical medicine. Automatic kidney segmentation in US images with AI has not progressed recently. Thus, there is a need for further development of US-based kidney imaging and segmentation to understand the problems and improve the performance of the AI models in segmentation.

In the first study to measure total kidney volume from 3D US images using deep learning, the researchers used axially acquired 3D US-kidney images in 22 ADPKD patients where each patient and each kidney were scanned three times, resulting in 132 scans that were manually segmented. The researchers trained a convolutional neural network to segment the whole kidney and measure TKV. All patients were subsequently imaged with MRI for measurement comparison. The researchers found that the method showed promising segmentation performance for auto-segmentation of kidneys and calculating total kidney volume, close to human tracing, and measurement. The researchers also compared its performance with MRI, and found that it achieved good performance, suggesting it may be useful in populations where MRI is more challenging, such as children.

Related Links:
Mayo Clinic

3T MRI Scanner
MAGNETOM Cima.X
New
Digital Intelligent Ferromagnetic Detector
Digital Ferromagnetic Detector
Computed Tomography System
Aquilion ONE / INSIGHT Edition
New
Biopsy Software
Affirm® Contrast

Print article

Channels

Radiography

view channel
Image: AI can identify “mammographically-visible” types of interval cancers earlier by flagging them at the time of screening (Photo courtesy of ScreenPoint Medical)

AI Improves Early Detection of Interval Breast Cancers

Interval breast cancers, which occur between routine screenings, are easier to treat when detected earlier. Early detection can reduce the need for aggressive treatments and improve the chances of better outcomes.... Read more

MRI

view channel
Image: An MRI scan can reveal a heart’s functional age (Photo courtesy of 123RF)

New MRI Technique Reveals True Heart Age to Prevent Attacks and Strokes

Heart disease remains one of the leading causes of death worldwide. Individuals with conditions such as diabetes or obesity often experience accelerated aging of their hearts, sometimes by decades.... Read more

Nuclear Medicine

view channel
Image: In vivo imaging of U-87 MG xenograft model with varying mass doses of 89Zr-labeled KLG-3 or isotype control (Photo courtesy of L Gajecki et al.; doi.org/10.2967/jnumed.124.268762)

Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors

Interleukin-13 receptor α-2 (IL13Rα2) is a cell surface receptor commonly found in solid tumors such as glioblastoma, melanoma, and breast cancer. It is minimally expressed in normal tissues, making it... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.